Nature Reviews Gastroenterology & Hepatology

(The TQCC of Nature Reviews Gastroenterology & Hepatology is 62. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)
A global view of hepatocellular carcinoma: trends, risk, prevention and management1644
The role of short-chain fatty acids in microbiota–gut–brain communication960
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies870
You are what you eat: diet, health and the gut microbiota686
Immunotherapy in colorectal cancer: rationale, challenges and potential653
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic648
From NASH to HCC: current concepts and future challenges610
Tales from the crypt: new insights into intestinal stem cells432
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications431
Molecular subtypes of pancreatic cancer399
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis387
Tumour evolution in hepatocellular carcinoma331
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD299
Alcohol, liver disease and the gut microbiota285
Global epidemiology and holistic prevention of pancreatitis285
Past, present and future perspectives in nonalcoholic fatty liver disease269
New insights into acute pancreatitis256
Cancer-associated fibroblasts in gastrointestinal cancer234
Wnt–β-catenin signalling in liver development, health and disease221
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting217
Cholangiocyte pathobiology210
Spatial heterogeneity in the mammalian liver184
The changing epidemiology of liver diseases in the Asia–Pacific region161
Adaptive immunity: an emerging player in the progression of NAFLD145
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology141
NAFLD in children: new genes, new diagnostic modalities and new drugs129
Management of functional constipation in children and adults120
Microbiota in pancreatic health and disease: the next frontier in microbiome research118
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators114
The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases111
The role of telomeres and telomerase in cirrhosis and liver cancer108
Metabolic rearrangements in primary liver cancers: cause and consequences103
Primary biliary cholangitis: pathogenesis and therapeutic opportunities98
Fatigue in IBD: epidemiology, pathophysiology and management97
Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines96
Hepatic microcirculation and mechanisms of portal hypertension95
Insights into the success and failure of systemic therapy for hepatocellular carcinoma92
Intestinal gases: influence on gut disorders and the role of dietary manipulations83
First translational consensus on terminology and definitions of colonic motility in animals and humans studied by manometric and other techniques83
Big data in IBD: a look into the future81
Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms78
Control and dysregulation of redox signalling in the gastrointestinal tract75
Restoring, releasing or replacing adaptive immunity in chronic hepatitis B69
Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics62